Disease-modifying therapy adherence and associated factors in a national sample of Medicare patients with multiple sclerosis

Authors

Pengxiang Li, University of Pennsylvania
Vrushabh P Ladage, University of Pennsylvania
Joseph Berger, University of Pennsylvania
Salim Chahin, Washington University School of Medicine in St. Louis
Mehul Jhaveri, Biogen, Cambridge
Caroline Geremakis, Biogen, Weston
Jalpa A Doshi, University of Pennsylvania

Journal

Value in health

Publication Date

3-1-2020

Volume

23

Issue

3

First Page

328

Last Page

334

Document Type

Open Access Publication

DOI

10.1016/j.jval.2019.10.011

Rights and Permissions

Li P, Ladage VP, Berger J, Chahin S, Jhaveri M, Geremakis C, Doshi JA. Disease-Modifying Therapy Adherence and Associated Factors in a National Sample of Medicare Patients With Multiple Sclerosis. Value Health. 2020 Mar;23(3):328-334. doi: 10.1016/j.jval.2019.10.011. Copyright 2019, ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).https://doi.org/10.1016/j.jval.2019.10.011

Recommended Citation

Li, Pengxiang; Ladage, Vrushabh P; Berger, Joseph; Chahin, Salim; Jhaveri, Mehul; Geremakis, Caroline; and Doshi, Jalpa A, "Disease-modifying therapy adherence and associated factors in a national sample of Medicare patients with multiple sclerosis." Value in health. 23, 3. 328 - 334. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9542